English
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#gynonc search results

IJGConline's profile picture. IJGC is the primary publication for detection, prevention, diagnosis, & treatment of #GynCancer #GynOnc
IJGC
@IJGConline
Sep 16

We’re so excited to welcome Zaniru Marín @ZaniruRaul, a #GynOnc trained at the Instituto Nacional de Cancerología #INCan in México 🇲🇽 Let’s give him a warm welcome! 🙌🌟 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert…

IJGConline's tweet image. We’re so excited to welcome Zaniru Marín @ZaniruRaul, a #GynOnc trained at the Instituto Nacional de Cancerología #INCan in México 🇲🇽 Let’s give him a warm welcome! 🙌🌟 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert…
0
3
17
0
1K
ESGO_society's profile picture. ESGO advances treatment, care & research of gynae cancers and offers members & non-members a variety of ways to advance their professional development.
ESGO
@ESGO_society
Oct 20

Newly published 🔥🗞️: The ESGO Position Statement on promoting inclusive surgical ergonomics in #gynonc! Read it here 👉sciencedirect.com/science/articl… Highlights: ℹ️ Poorly designed instruments & operating theatre environments contribute to musculoskeletal injuries, fatigue, &…

1
6
21
2
917
IJGConline's profile picture. IJGC is the primary publication for detection, prevention, diagnosis, & treatment of #GynCancer #GynOnc
IJGC
@IJGConline
Sep 19

#EditorialFellows We are pleased to welcome Matteo Loverro @MatteoLoverro, #GynOnc at the Fondazione Policlinico Universitario A. Gemelli, in Rome 🇮🇹 ✨ Welcome, Matteo! We’re really looking forward to working with you. @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2…

IJGConline's tweet image. #EditorialFellows We are pleased to welcome Matteo Loverro @MatteoLoverro, #GynOnc at the Fondazione Policlinico Universitario A. Gemelli, in Rome 🇮🇹 ✨ Welcome, Matteo! We’re really looking forward to working with you. @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2…
0
5
13
0
1K
Path4People's profile picture. Pathologist 🔬. Co-creator of YouTube’s Pathagonia with @biehlcole. Views = My Own, not my Organization’s. Check us out😃! https://t.co/qC4da8aMpY
Jay "Thymocyte" Hwang
 @Path4People
Sep 4, 2024

📚Sertoli-Leydig Cell Tumor (Ovary) 📕 Sex Cord Stromal Tumor 2️⃣ Cells: Sertoli + Leydig cells 📈 ~97% Unilateral 📊 Average age+size: 25 y/o+13cm 📈 40-60% w androgenic symptoms 🧬 Ass DICER1 syndrome ➗Well;mod;poorly diff based on tubular diff of Sertoli cell 🎨SF1+ #gynonc

Path4People's tweet image. 📚Sertoli-Leydig Cell Tumor (Ovary) 📕 Sex Cord Stromal Tumor 2️⃣ Cells: Sertoli + Leydig cells 📈 ~97% Unilateral 📊 Average age+size: 25 y/o+13cm 📈 40-60% w androgenic symptoms 🧬 Ass DICER1 syndrome ➗Well;mod;poorly diff based on tubular diff of Sertoli cell 🎨SF1+ #gynonc
Path4People's tweet image. 📚Sertoli-Leydig Cell Tumor (Ovary) 📕 Sex Cord Stromal Tumor 2️⃣ Cells: Sertoli + Leydig cells 📈 ~97% Unilateral 📊 Average age+size: 25 y/o+13cm 📈 40-60% w androgenic symptoms 🧬 Ass DICER1 syndrome ➗Well;mod;poorly diff based on tubular diff of Sertoli cell 🎨SF1+ #gynonc
Path4People's tweet image. 📚Sertoli-Leydig Cell Tumor (Ovary) 📕 Sex Cord Stromal Tumor 2️⃣ Cells: Sertoli + Leydig cells 📈 ~97% Unilateral 📊 Average age+size: 25 y/o+13cm 📈 40-60% w androgenic symptoms 🧬 Ass DICER1 syndrome ➗Well;mod;poorly diff based on tubular diff of Sertoli cell 🎨SF1+ #gynonc
Path4People's tweet image. 📚Sertoli-Leydig Cell Tumor (Ovary) 📕 Sex Cord Stromal Tumor 2️⃣ Cells: Sertoli + Leydig cells 📈 ~97% Unilateral 📊 Average age+size: 25 y/o+13cm 📈 40-60% w androgenic symptoms 🧬 Ass DICER1 syndrome ➗Well;mod;poorly diff based on tubular diff of Sertoli cell 🎨SF1+ #gynonc
1
12
55
11
4K
WashUMedRadOnc's profile picture. Recognized leaders in exceptional patient care, education and research. Affiliated with @SitemanCenter, @WashUmedicine, @BarnesJewish, @STLChildrens.
WashU Medicine Radiation Oncology
 @WashUMedRadOnc
May 3, 2023

Our residents with Dr. Surbhi Grover, our Wasserman Lecturer, and our #Gynonc team - before their Q&A time.

WashUMedRadOnc's tweet image. Our residents with Dr. Surbhi Grover, our Wasserman Lecturer, and our #Gynonc team - before their Q&A time.
0
3
24
0
3K
Path4People's profile picture. Pathologist 🔬. Co-creator of YouTube’s Pathagonia with @biehlcole. Views = My Own, not my Organization’s. Check us out😃! https://t.co/qC4da8aMpY
Jay "Thymocyte" Hwang
 @Path4People
Jan 13, 2024

Uterine Carcinosarcoma is an interesting tumor to me as a pathologist. It’s a tumor composed of frankly malignant epithelial AND stromal cells. It’s thought that the epithelial component transdifferentiates into a soft tissue component #pathagonia #gynonc #pathx #pathology

Path4People's tweet image. Uterine Carcinosarcoma is an interesting tumor to me as a pathologist. It’s a tumor composed of frankly malignant epithelial AND stromal cells. It’s thought that the epithelial component transdifferentiates into a soft tissue component #pathagonia #gynonc #pathx #pathology
Path4People's tweet image. Uterine Carcinosarcoma is an interesting tumor to me as a pathologist. It’s a tumor composed of frankly malignant epithelial AND stromal cells. It’s thought that the epithelial component transdifferentiates into a soft tissue component #pathagonia #gynonc #pathx #pathology
Path4People's tweet image. Uterine Carcinosarcoma is an interesting tumor to me as a pathologist. It’s a tumor composed of frankly malignant epithelial AND stromal cells. It’s thought that the epithelial component transdifferentiates into a soft tissue component #pathagonia #gynonc #pathx #pathology
3
21
58
16
3K
ESGO_society's profile picture. ESGO advances treatment, care & research of gynae cancers and offers members & non-members a variety of ways to advance their professional development.
ESGO
@ESGO_society
Nov 16

WEDNESDAY: Don’t miss the November @IJGConline Club with Brian M Slomovitz! Join here: esgo.org/zoom-journal-c… #gynonc #IJGCclub #oncoalert

ESGO_society's tweet image. WEDNESDAY: Don’t miss the November @IJGConline Club with Brian M Slomovitz! Join here: esgo.org/zoom-journal-c… #gynonc #IJGCclub #oncoalert
0
0
4
1
262
WashUMedRadOnc's profile picture. Recognized leaders in exceptional patient care, education and research. Affiliated with @SitemanCenter, @WashUmedicine, @BarnesJewish, @STLChildrens.
WashU Medicine Radiation Oncology
 @WashUMedRadOnc
Dec 17

Our #GynOnc 🌟 Dr. @SMarkovina2 has been awarded tenure. Extremely well deserved! @WashUDPS

WashUMedRadOnc's tweet image. Our #GynOnc 🌟 Dr. @SMarkovina2 has been awarded tenure. Extremely well deserved! @WashUDPS
7
5
32
0
2K
dukeobgyn's profile picture. The Department of Ob/Gyn at Duke University School of Medicine is dedicated to advancing the care of women through research, education, and patient care.
Duke Ob/Gyn
 @dukeobgyn
Nov 10

Kudos to #GynOnc Andrew Berchuck, MD, recipient of the prestigious Shingleton Award for Caregiver Partnership. The award is named in honor of William W. Shingleton, MD, founding director of Duke Comprehensive Cancer Center. 🔗duke.is/ShingletonAwar…

dukeobgyn's tweet image. Kudos to #GynOnc Andrew Berchuck, MD, recipient of the prestigious Shingleton Award for Caregiver Partnership. The award is named in honor of William W. Shingleton, MD, founding director of Duke Comprehensive Cancer Center. 🔗duke.is/ShingletonAwar…
dukeobgyn's tweet image. Kudos to #GynOnc Andrew Berchuck, MD, recipient of the prestigious Shingleton Award for Caregiver Partnership. The award is named in honor of William W. Shingleton, MD, founding director of Duke Comprehensive Cancer Center. 🔗duke.is/ShingletonAwar…
0
2
8
0
717
ESGO_society's profile picture. ESGO advances treatment, care & research of gynae cancers and offers members & non-members a variety of ways to advance their professional development.
ESGO
@ESGO_society
Nov 11

Ready to take a side on some hot 🔥 topics in #gynonc? We’re looking forward to bringing you 3 debate sessions at #ESGO2026 in Copenhagen! For example, this one, which centres on the recently completed TRUST trial. Sven Mahner 🇩🇪 will argue in favour of radical surgery for…

ESGO_society's tweet image. Ready to take a side on some hot 🔥 topics in #gynonc? We’re looking forward to bringing you 3 debate sessions at #ESGO2026 in Copenhagen! For example, this one, which centres on the recently completed TRUST trial. Sven Mahner 🇩🇪 will argue in favour of radical surgery for…
0
4
13
0
807
Path4People's profile picture. Pathologist 🔬. Co-creator of YouTube’s Pathagonia with @biehlcole. Views = My Own, not my Organization’s. Check us out😃! https://t.co/qC4da8aMpY
Jay "Thymocyte" Hwang
 @Path4People
Apr 4

63 y/o post menopausal woman with abnormal uterine bleeding 🩸 Imaging found a polyp. Biopsy and subsequent hysterectomy done. Sample of polyp 👇 IHC: p53 mutant, p16 diffuse. Dx? 🤔 #gynpath #gynonc #pathx

Path4People's tweet image. 63 y/o post menopausal woman with abnormal uterine bleeding 🩸 Imaging found a polyp. Biopsy and subsequent hysterectomy done. Sample of polyp 👇 IHC: p53 mutant, p16 diffuse. Dx? 🤔 #gynpath #gynonc #pathx
Path4People's tweet image. 63 y/o post menopausal woman with abnormal uterine bleeding 🩸 Imaging found a polyp. Biopsy and subsequent hysterectomy done. Sample of polyp 👇 IHC: p53 mutant, p16 diffuse. Dx? 🤔 #gynpath #gynonc #pathx
Path4People's tweet image. 63 y/o post menopausal woman with abnormal uterine bleeding 🩸 Imaging found a polyp. Biopsy and subsequent hysterectomy done. Sample of polyp 👇 IHC: p53 mutant, p16 diffuse. Dx? 🤔 #gynpath #gynonc #pathx
Path4People's tweet image. 63 y/o post menopausal woman with abnormal uterine bleeding 🩸 Imaging found a polyp. Biopsy and subsequent hysterectomy done. Sample of polyp 👇 IHC: p53 mutant, p16 diffuse. Dx? 🤔 #gynpath #gynonc #pathx
2
9
22
8
2K
WashUMedRadOnc's profile picture. Recognized leaders in exceptional patient care, education and research. Affiliated with @SitemanCenter, @WashUmedicine, @BarnesJewish, @STLChildrens.
WashU Medicine Radiation Oncology
 @WashUMedRadOnc
May 3, 2023

Thanks to Dr. Surbhi Grover for a fantastic Wasserman Lecture about #gynonc in Botswana & showing how collaborative research can help around the globe. #Womenwhocurie

WashUMedRadOnc's tweet image. Thanks to Dr. Surbhi Grover for a fantastic Wasserman Lecture about #gynonc in Botswana & showing how collaborative research can help around the globe. #Womenwhocurie
WashUMedRadOnc's tweet image. Thanks to Dr. Surbhi Grover for a fantastic Wasserman Lecture about #gynonc in Botswana & showing how collaborative research can help around the globe. #Womenwhocurie
0
1
29
0
2K
ESGO_society's profile picture. ESGO advances treatment, care & research of gynae cancers and offers members & non-members a variety of ways to advance their professional development.
ESGO
@ESGO_society
Nov 7

ESGO President Anna Fagotti, former ESGO President Denis Querleu & Prof Francesco Fanfani invite you to a special #MeettheSurgeon webinar discussion on personalised surgical management! 📆 Nov 27 18h Sign up via the ESGO eAcademy 🙌 #gynonc #surgery #oncoalert

ESGO_society's tweet image. ESGO President Anna Fagotti, former ESGO President Denis Querleu & Prof Francesco Fanfani invite you to a special #MeettheSurgeon webinar discussion on personalised surgical management! 📆 Nov 27 18h Sign up via the ESGO eAcademy 🙌 #gynonc #surgery #oncoalert
0
4
8
1
787
mboyer_do's profile picture. Gynecologic Oncology Fellow at @UR_Med Greyhound mom, coffee enthusiast, avid knitter.
Megan Boyer, DO, MS
 @mboyer_do
Sep 28, 2024

It’s a Match! We’re headed to University of Rochester for Gynecologic Oncology fellowship! Thank you everyone who helped make this dream a reality. #gynonc #obgynmatch @SGO_org @acog @acogd3 @AOAforDOs

mboyer_do's tweet image. It’s a Match! We’re headed to University of Rochester for Gynecologic Oncology fellowship! Thank you everyone who helped make this dream a reality. #gynonc #obgynmatch @SGO_org @acog @acogd3 @AOAforDOs
mboyer_do's tweet image. It’s a Match! We’re headed to University of Rochester for Gynecologic Oncology fellowship! Thank you everyone who helped make this dream a reality. #gynonc #obgynmatch @SGO_org @acog @acogd3 @AOAforDOs
18
4
431
7
27K
BPothuri's profile picture. Gynecologic Oncologist, parent, advocate for patients with Gyn cancer. Opinions are mine not NYU Langone School of Medicine
Bhavana Pothuri
 @BPothuri
Sep 15

What an amazing day- installation of Floor Backes as the Larry Copeland Professor at OSU James! Thanks Cope for your generosity and tremendous contributions to #gynonc and congrats ⁦@FBackesMD⁩- so well deserved! ⁦@GOG⁩ ⁦@SGO_org⁩ ⁦@IGCSociety⁩ ⁦@acog

BPothuri's tweet image. What an amazing day- installation of Floor Backes as the Larry Copeland Professor at OSU James! Thanks Cope for your generosity and tremendous contributions to #gynonc and congrats ⁦@FBackesMD⁩- so well deserved! ⁦@GOG⁩ ⁦@SGO_org⁩ ⁦@IGCSociety⁩ ⁦@acog
0
4
14
0
924
OncoAlert's profile picture. 🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨
OncoAlert
@OncoAlert
Oct 20

Dear #GynOnc Colleagues at #ESMO25 Nothing beats Good Partners, the only way to get farther together. OncoAlert is a Proud Partner of @ESGO_society 🚨and @IJGConline Here we would like to share some of their initiatives Pinging @NicoloBizzarri @CoquardRay @ChargariC…

0
6
11
0
800
ozdogan_md's profile picture. Oncologist. Cancer treatment & care in Turkey. Current advances, future directions and second opinion... Let's create a society which is not afraid of cancer!
Mustafa Özdoğan, MD
@ozdogan_md
Oct 19

For the first time, a significant overall survival benefit with immunotherapy in platinum-resistant ovarian cancer! #ESMO25 #Immunotherapy #GynOnc #KeynoteB96 #Oncology @myESMO @OncLive @CParkMD @tugbawitter @Dr_ElvinaA @atakansare2016 @drmukremin @dr_yakupergun @OncoAlert…

ozdogan_md's tweet image. For the first time, a significant overall survival benefit with immunotherapy in platinum-resistant ovarian cancer! #ESMO25 #Immunotherapy #GynOnc #KeynoteB96 #Oncology @myESMO @OncLive @CParkMD @tugbawitter @Dr_ElvinaA @atakansare2016 @drmukremin @dr_yakupergun @OncoAlert…
0
29
57
23
5K
ENYGO_official's profile picture. The European Network of Young Gynae Oncologists (ENYGO) is a network for juniors and trainees in Gynaecological Oncology and related subspecialties.
European Network of Young Gynae Oncologists
 @ENYGO_official
Jun 28

🎯 Precision medicine in gynae cancer 📍 Vienna | Nov 17–18, 2025 🔬 Focus on molecular pathology & targeted therapies in endometrial & ovarian cancer 👩⚕️ Limited spots – register now! 📩 [email protected] #ESGOsociety #GynOnc #PrecisionMedicine #pathology

1
5
9
0
480
ESGO_society's profile picture. ESGO advances treatment, care & research of gynae cancers and offers members & non-members a variety of ways to advance their professional development.
ESGO
@ESGO_society
Nov 16

WEDNESDAY: Don’t miss the November @IJGConline Club with Brian M Slomovitz! Join here: esgo.org/zoom-journal-c… #gynonc #IJGCclub #oncoalert

ESGO_society's tweet image. WEDNESDAY: Don’t miss the November @IJGConline Club with Brian M Slomovitz! Join here: esgo.org/zoom-journal-c… #gynonc #IJGCclub #oncoalert
0
0
4
1
262
MeganLeigh127's profile picture. She/Her/Dr. Gynecologic Oncologist @Carle_org APD @CarleOb_Gyn Clinical Assistant Teaching Prof @ILLINOISmed Millennial Opinions Mine. I’m back.
Megan Hutchcraft MD
 @MeganLeigh127
Nov 16

We are so excited to announce current trial reports! A great option if you are looking to spread the word about your trial, adding additional clinical sites, or recruiting patients! #gynonc #research #clinicaltrials #cancerresearch #researchsaveslives

gynoncjnls's profile picture. Gynecologic Oncology & Gynecologic Oncology Reports Journals @David_Cohn_MD @SusanModesitt #SocialMediaEditor @MeganLeigh127 and @TeresaBoitano
@GynOncJnls
@gynoncjnls
Nov 14

New Article Type: Current Trial Reports! A new article format designed to highlight ongoing #ClinicalTrials: their purpose, design, eligibility, and treatment plan. No final outcome data (trials still in progress!). Recommended: 500–1500 words, 1–2 figures, 5–15 references.…

gynoncjnls's tweet image. New Article Type: Current Trial Reports! A new article format designed to highlight ongoing #ClinicalTrials: their purpose, design, eligibility, and treatment plan. No final outcome data (trials still in progress!). Recommended: 500–1500 words, 1–2 figures, 5–15 references.…
0
1
3
0
344
0
0
1
0
52
cancer_nurses's profile picture. Cancer Nursing Today delivers the latest in cancer news and published literature, providing cancer nurses access to curated topics.
Cancer Nursing Today
 @cancer_nurses
Nov 16

📹 What's the best method of endometrial cancer surveillance? ♀️ A recent study led by researchers from Japan compared the effectiveness of vaginal cytology versus a traditional pelvic examination in detecting endometrial cancer. ➡️ Read more: buff.ly/eFHbrPa #gynonc

cancer_nurses's tweet image. 📹 What's the best method of endometrial cancer surveillance? ♀️ A recent study led by researchers from Japan compared the effectiveness of vaginal cytology versus a traditional pelvic examination in detecting endometrial cancer. ➡️ Read more: buff.ly/eFHbrPa #gynonc
0
0
0
0
49
VJOncology's profile picture. The Video Journal of Oncology is dedicated to providing up-to-date information & international expertise on #Oncology #BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm
VJ Oncology
@VJOncology
Nov 11

At #ESMO25, Antonio González-Martín, MD, shares ANITA trial biomarker insights in recurrent #OvarianCancer: high baseline VISTA & VEGF-A linked to poorer PFS & OS, aiding early risk stratification. 🎥 Watch: ow.ly/g75L50Xq0gq #GynOnc #GyncSM #Oncology @myESMO

VJOncology's tweet card. Antonio González-Martín, MD, University of Navarra, Pamplona, Spain, explores baseline multiplex cytokine profiling from the Phase III ANITA trial (NCT03598270) in recurrent ovarian cancer. Analyses...
ANITA: baseline cytokine profiling as a prognostic marker in recurrent ovarian cancer
Source: vjoncology.com
0
0
0
0
251
ESGO_society's profile picture. ESGO advances treatment, care & research of gynae cancers and offers members & non-members a variety of ways to advance their professional development.
ESGO
@ESGO_society
Nov 11

Ready to take a side on some hot 🔥 topics in #gynonc? We’re looking forward to bringing you 3 debate sessions at #ESGO2026 in Copenhagen! For example, this one, which centres on the recently completed TRUST trial. Sven Mahner 🇩🇪 will argue in favour of radical surgery for…

ESGO_society's tweet image. Ready to take a side on some hot 🔥 topics in #gynonc? We’re looking forward to bringing you 3 debate sessions at #ESGO2026 in Copenhagen! For example, this one, which centres on the recently completed TRUST trial. Sven Mahner 🇩🇪 will argue in favour of radical surgery for…
0
4
13
0
807
EJGO_1980's profile picture. Aims and scope European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal.
EJGO
 @EJGO_1980
Nov 11

⚡LEEP + chemo beats trachelectomy in early #CervicalCancer: faster recovery, 3-yr lower recurrence! 🩺 #GynOnc #LEEP 📚Read more:ejgo.net/articles/10.22…

EJGO_1980's tweet image. ⚡LEEP + chemo beats trachelectomy in early #CervicalCancer: faster recovery, 3-yr lower recurrence! 🩺 #GynOnc #LEEP 📚Read more:ejgo.net/articles/10.22…
0
0
1
1
32
dukeobgyn's profile picture. The Department of Ob/Gyn at Duke University School of Medicine is dedicated to advancing the care of women through research, education, and patient care.
Duke Ob/Gyn
 @dukeobgyn
Nov 10

Kudos to #GynOnc Andrew Berchuck, MD, recipient of the prestigious Shingleton Award for Caregiver Partnership. The award is named in honor of William W. Shingleton, MD, founding director of Duke Comprehensive Cancer Center. 🔗duke.is/ShingletonAwar…

dukeobgyn's tweet image. Kudos to #GynOnc Andrew Berchuck, MD, recipient of the prestigious Shingleton Award for Caregiver Partnership. The award is named in honor of William W. Shingleton, MD, founding director of Duke Comprehensive Cancer Center. 🔗duke.is/ShingletonAwar…
dukeobgyn's tweet image. Kudos to #GynOnc Andrew Berchuck, MD, recipient of the prestigious Shingleton Award for Caregiver Partnership. The award is named in honor of William W. Shingleton, MD, founding director of Duke Comprehensive Cancer Center. 🔗duke.is/ShingletonAwar…
0
2
8
0
717
ESGO_society's profile picture. ESGO advances treatment, care & research of gynae cancers and offers members & non-members a variety of ways to advance their professional development.
ESGO
@ESGO_society
Nov 10

Reminder! 🤓👋 The final day to apply for the ESGO 12-month mentorship programme starting in 2026 is Nov 20! We are accepting applications from potential mentors & from potential mentees. Learn more & apply! 👉esgo.org/mentorship-pro… #gynonc #leadership

ESGO_society's tweet image. Reminder! 🤓👋 The final day to apply for the ESGO 12-month mentorship programme starting in 2026 is Nov 20! We are accepting applications from potential mentors & from potential mentees. Learn more & apply! 👉esgo.org/mentorship-pro… #gynonc #leadership
1
1
8
4
789
EJGO_1980's profile picture. Aims and scope European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal.
EJGO
 @EJGO_1980
Nov 10

👨‍👩‍👧‍👦Family empowerment cuts shame & boosts QoL in catheterized #CervicalCancer patients! 💪 #EmpowermentEducation #GynOnc 📚Read more:ejgo.net/articles/10.22…

EJGO_1980's tweet image. 👨‍👩‍👧‍👦Family empowerment cuts shame & boosts QoL in catheterized #CervicalCancer patients! 💪 #EmpowermentEducation #GynOnc 📚Read more:ejgo.net/articles/10.22…
0
0
0
0
28
ESGO_society's profile picture. ESGO advances treatment, care & research of gynae cancers and offers members & non-members a variety of ways to advance their professional development.
ESGO
@ESGO_society
Nov 7

TUESDAY: Don’t miss our ESGO Prevention webinar focused on oncogenetics! It will include some interesting research on Lynch Syndrome and endometrial and ovarian cancer risk presented by Claudia Marchetti! All details 👉 esgo.org/prevention/ #gynonc #oncoalert

0
4
11
0
401
ESGO_society's profile picture. ESGO advances treatment, care & research of gynae cancers and offers members & non-members a variety of ways to advance their professional development.
ESGO
@ESGO_society
Nov 7

ESGO President Anna Fagotti, former ESGO President Denis Querleu & Prof Francesco Fanfani invite you to a special #MeettheSurgeon webinar discussion on personalised surgical management! 📆 Nov 27 18h Sign up via the ESGO eAcademy 🙌 #gynonc #surgery #oncoalert

ESGO_society's tweet image. ESGO President Anna Fagotti, former ESGO President Denis Querleu & Prof Francesco Fanfani invite you to a special #MeettheSurgeon webinar discussion on personalised surgical management! 📆 Nov 27 18h Sign up via the ESGO eAcademy 🙌 #gynonc #surgery #oncoalert
0
4
8
1
787
sherfani's profile picture. Gynecologic Oncology Fellow @USC @KeckMedUSC @uscnorris • Prior ObGyn Resident @bcmhouston 🇮🇷 🇺🇸
Hadi Erfani, MD, MPH
 @sherfani
Nov 7

👏 Excellent overview by Dr. Rauh-Hain at #IGCS2025 on fertility-sparing surgery in early-stage ovarian cancer. A great reminder: preserving fertility must go hand-in-hand with comprehensive staging to ensure oncologic safety. #GynOnc #OvarianCancer @IGCSociety @IJGConline

sherfani's tweet image. 👏 Excellent overview by Dr. Rauh-Hain at #IGCS2025 on fertility-sparing surgery in early-stage ovarian cancer. A great reminder: preserving fertility must go hand-in-hand with comprehensive staging to ensure oncologic safety. #GynOnc #OvarianCancer @IGCSociety @IJGConline
sherfani's tweet image. 👏 Excellent overview by Dr. Rauh-Hain at #IGCS2025 on fertility-sparing surgery in early-stage ovarian cancer. A great reminder: preserving fertility must go hand-in-hand with comprehensive staging to ensure oncologic safety. #GynOnc #OvarianCancer @IGCSociety @IJGConline
0
3
9
2
473
sherfani's profile picture. Gynecologic Oncology Fellow @USC @KeckMedUSC @uscnorris • Prior ObGyn Resident @bcmhouston 🇮🇷 🇺🇸
Hadi Erfani, MD, MPH
 @sherfani
Nov 7

Dr. Naumann reminds us at #IGCS2025 that oncology is not just about treatment—it's about public health. 💡 “Spending more doesn’t always mean living longer.” It’s time to invest smarter and strengthen public health oncology. 🌍 #GynOnc #GlobalOncology @IGCSociety @IJGConline

sherfani's tweet image. Dr. Naumann reminds us at #IGCS2025 that oncology is not just about treatment—it's about public health. 💡 “Spending more doesn’t always mean living longer.” It’s time to invest smarter and strengthen public health oncology. 🌍 #GynOnc #GlobalOncology @IGCSociety @IJGConline
0
2
5
1
414
sherfani's profile picture. Gynecologic Oncology Fellow @USC @KeckMedUSC @uscnorris • Prior ObGyn Resident @bcmhouston 🇮🇷 🇺🇸
Hadi Erfani, MD, MPH
 @sherfani
Nov 6

🌍 Inspiring presentation by Dr. Mukhopadhyay at #IGCS2025! Her work highlights how pragmatic trial design can adapt global standards—like PARPi Tx—to fit local realities and resources in India. Innovation = accessibility. 💡 #GynOnc #GlobalOncology @IGCSociety @IJGConline

sherfani's tweet image. 🌍 Inspiring presentation by Dr. Mukhopadhyay at #IGCS2025! Her work highlights how pragmatic trial design can adapt global standards—like PARPi Tx—to fit local realities and resources in India. Innovation = accessibility. 💡 #GynOnc #GlobalOncology @IGCSociety @IJGConline
sherfani's tweet image. 🌍 Inspiring presentation by Dr. Mukhopadhyay at #IGCS2025! Her work highlights how pragmatic trial design can adapt global standards—like PARPi Tx—to fit local realities and resources in India. Innovation = accessibility. 💡 #GynOnc #GlobalOncology @IGCSociety @IJGConline
sherfani's tweet image. 🌍 Inspiring presentation by Dr. Mukhopadhyay at #IGCS2025! Her work highlights how pragmatic trial design can adapt global standards—like PARPi Tx—to fit local realities and resources in India. Innovation = accessibility. 💡 #GynOnc #GlobalOncology @IGCSociety @IJGConline
0
4
9
0
457
sherfani's profile picture. Gynecologic Oncology Fellow @USC @KeckMedUSC @uscnorris • Prior ObGyn Resident @bcmhouston 🇮🇷 🇺🇸
Hadi Erfani, MD, MPH
 @sherfani
Nov 6

🚨 Another late-breaking highlight from #IGCS2025! Dr. Charlie Gourley presents the final OS results from the GOG281 trial, confirming Trametinib improves both PFS and OS vs standard therapy in rLGSOC — even with 72% crossover. 🔥 #GynOnc #OvarianCancer @IGCSociety @IJGConline

sherfani's tweet image. 🚨 Another late-breaking highlight from #IGCS2025! Dr. Charlie Gourley presents the final OS results from the GOG281 trial, confirming Trametinib improves both PFS and OS vs standard therapy in rLGSOC — even with 72% crossover. 🔥 #GynOnc #OvarianCancer @IGCSociety @IJGConline
sherfani's tweet image. 🚨 Another late-breaking highlight from #IGCS2025! Dr. Charlie Gourley presents the final OS results from the GOG281 trial, confirming Trametinib improves both PFS and OS vs standard therapy in rLGSOC — even with 72% crossover. 🔥 #GynOnc #OvarianCancer @IGCSociety @IJGConline
sherfani's tweet image. 🚨 Another late-breaking highlight from #IGCS2025! Dr. Charlie Gourley presents the final OS results from the GOG281 trial, confirming Trametinib improves both PFS and OS vs standard therapy in rLGSOC — even with 72% crossover. 🔥 #GynOnc #OvarianCancer @IGCSociety @IJGConline
0
5
12
1
655
sherfani's profile picture. Gynecologic Oncology Fellow @USC @KeckMedUSC @uscnorris • Prior ObGyn Resident @bcmhouston 🇮🇷 🇺🇸
Hadi Erfani, MD, MPH
 @sherfani
Nov 6

🚨 Late-breaking abstract at #IGCS2025! Dr. Su presents data on low-dose Lenvatinib + Toripalimab as a chemo-free option for platinum-resistant recurrent ovarian cancer — encouraging efficacy with improved tolerability. 💫 #GynOnc #OvarianCancer @IGCSociety @IJGConline

sherfani's tweet image. 🚨 Late-breaking abstract at #IGCS2025! Dr. Su presents data on low-dose Lenvatinib + Toripalimab as a chemo-free option for platinum-resistant recurrent ovarian cancer — encouraging efficacy with improved tolerability. 💫 #GynOnc #OvarianCancer @IGCSociety @IJGConline
sherfani's tweet image. 🚨 Late-breaking abstract at #IGCS2025! Dr. Su presents data on low-dose Lenvatinib + Toripalimab as a chemo-free option for platinum-resistant recurrent ovarian cancer — encouraging efficacy with improved tolerability. 💫 #GynOnc #OvarianCancer @IGCSociety @IJGConline
0
5
12
1
512
EJGO_1980's profile picture. Aims and scope European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal.
EJGO
 @EJGO_1980
Nov 6

👵Neoadjuvant chemo shines for elderly #OvarianCancer: short stays, low complications! 💉 #GynOnc #GeriatricCare 🏠Affiliation:@uniofbrighton 、@SussexUni 📚Read more:ejgo.net/articles/10.22…

EJGO_1980's tweet image. 👵Neoadjuvant chemo shines for elderly #OvarianCancer: short stays, low complications! 💉 #GynOnc #GeriatricCare 🏠Affiliation:@uniofbrighton 、@SussexUni 📚Read more:ejgo.net/articles/10.22…
0
0
2
1
59
sherfani's profile picture. Gynecologic Oncology Fellow @USC @KeckMedUSC @uscnorris • Prior ObGyn Resident @bcmhouston 🇮🇷 🇺🇸
Hadi Erfani, MD, MPH
 @sherfani
Nov 5

💜 Truly inspiring start to the vulvar cancer session at #IGCS2025. So wonderful to have patients joining and sharing their experiences. We are so proud of you, Annalise! 🌸 #GynOnc #PatientVoice #CancerSurvivorship @IGCSociety @IJGConline

sherfani's tweet image. 💜 Truly inspiring start to the vulvar cancer session at #IGCS2025. So wonderful to have patients joining and sharing their experiences. We are so proud of you, Annalise! 🌸 #GynOnc #PatientVoice #CancerSurvivorship @IGCSociety @IJGConline
0
3
4
0
438
PennMDForum's profile picture. We share clinical updates about the physicians and providers, research, programs and initiatives at @PennMedicine and @Penn's Perelman School of Medicine.
Penn Medicine MD
 @PennMDForum
Nov 5

Meet Lori Cory, MD, MSCE, board-certified gynecologic oncologist and Medical Director of Women’s Surgical Oncology, sees patients at the Ann B. Barshinger Cancer Institute in Lancaster, PA. #GynOnc @LGHealth spr.ly/60187zLaQ

0
0
0
0
106
sherfani's profile picture. Gynecologic Oncology Fellow @USC @KeckMedUSC @uscnorris • Prior ObGyn Resident @bcmhouston 🇮🇷 🇺🇸
Hadi Erfani, MD, MPH
 @sherfani
Nov 5

🌍 Grateful to @IGCSociety for connecting #GynOncs from across the globe! It’s been wonderful meeting the incredible leaders of the #GynOnc from 🇮🇷 — doing remarkable work for women’s cancer care. 🤝 Collaboration knows no borders 🇮🇷🇺🇸 🇿🇦 🌎 #IGCS2025 #GlobalOncology

sherfani's tweet image. 🌍 Grateful to @IGCSociety for connecting #GynOncs from across the globe! It’s been wonderful meeting the incredible leaders of the #GynOnc from 🇮🇷 — doing remarkable work for women’s cancer care. 🤝 Collaboration knows no borders 🇮🇷🇺🇸 🇿🇦 🌎 #IGCS2025 #GlobalOncology
0
2
8
0
490
WashUMedRadOnc's profile picture. Recognized leaders in exceptional patient care, education and research. Affiliated with @SitemanCenter, @WashUmedicine, @BarnesJewish, @STLChildrens.
WashU Medicine Radiation Oncology
 @WashUMedRadOnc
May 3, 2023

Our residents with Dr. Surbhi Grover, our Wasserman Lecturer, and our #Gynonc team - before their Q&A time.

WashUMedRadOnc's tweet image. Our residents with Dr. Surbhi Grover, our Wasserman Lecturer, and our #Gynonc team - before their Q&A time.
0
3
24
0
3K
Path4People's profile picture. Pathologist 🔬. Co-creator of YouTube’s Pathagonia with @biehlcole. Views = My Own, not my Organization’s. Check us out😃! https://t.co/qC4da8aMpY
Jay "Thymocyte" Hwang
 @Path4People
Sep 4, 2024

📚Sertoli-Leydig Cell Tumor (Ovary) 📕 Sex Cord Stromal Tumor 2️⃣ Cells: Sertoli + Leydig cells 📈 ~97% Unilateral 📊 Average age+size: 25 y/o+13cm 📈 40-60% w androgenic symptoms 🧬 Ass DICER1 syndrome ➗Well;mod;poorly diff based on tubular diff of Sertoli cell 🎨SF1+ #gynonc

Path4People's tweet image. 📚Sertoli-Leydig Cell Tumor (Ovary) 📕 Sex Cord Stromal Tumor 2️⃣ Cells: Sertoli + Leydig cells 📈 ~97% Unilateral 📊 Average age+size: 25 y/o+13cm 📈 40-60% w androgenic symptoms 🧬 Ass DICER1 syndrome ➗Well;mod;poorly diff based on tubular diff of Sertoli cell 🎨SF1+ #gynonc
Path4People's tweet image. 📚Sertoli-Leydig Cell Tumor (Ovary) 📕 Sex Cord Stromal Tumor 2️⃣ Cells: Sertoli + Leydig cells 📈 ~97% Unilateral 📊 Average age+size: 25 y/o+13cm 📈 40-60% w androgenic symptoms 🧬 Ass DICER1 syndrome ➗Well;mod;poorly diff based on tubular diff of Sertoli cell 🎨SF1+ #gynonc
Path4People's tweet image. 📚Sertoli-Leydig Cell Tumor (Ovary) 📕 Sex Cord Stromal Tumor 2️⃣ Cells: Sertoli + Leydig cells 📈 ~97% Unilateral 📊 Average age+size: 25 y/o+13cm 📈 40-60% w androgenic symptoms 🧬 Ass DICER1 syndrome ➗Well;mod;poorly diff based on tubular diff of Sertoli cell 🎨SF1+ #gynonc
Path4People's tweet image. 📚Sertoli-Leydig Cell Tumor (Ovary) 📕 Sex Cord Stromal Tumor 2️⃣ Cells: Sertoli + Leydig cells 📈 ~97% Unilateral 📊 Average age+size: 25 y/o+13cm 📈 40-60% w androgenic symptoms 🧬 Ass DICER1 syndrome ➗Well;mod;poorly diff based on tubular diff of Sertoli cell 🎨SF1+ #gynonc
1
12
55
11
4K
WashUMedRadOnc's profile picture. Recognized leaders in exceptional patient care, education and research. Affiliated with @SitemanCenter, @WashUmedicine, @BarnesJewish, @STLChildrens.
WashU Medicine Radiation Oncology
 @WashUMedRadOnc
Dec 17

Our #GynOnc 🌟 Dr. @SMarkovina2 has been awarded tenure. Extremely well deserved! @WashUDPS

WashUMedRadOnc's tweet image. Our #GynOnc 🌟 Dr. @SMarkovina2 has been awarded tenure. Extremely well deserved! @WashUDPS
7
5
32
0
2K
IJGConline's profile picture. IJGC is the primary publication for detection, prevention, diagnosis, & treatment of #GynCancer #GynOnc
IJGC
@IJGConline
Sep 16

We’re so excited to welcome Zaniru Marín @ZaniruRaul, a #GynOnc trained at the Instituto Nacional de Cancerología #INCan in México 🇲🇽 Let’s give him a warm welcome! 🙌🌟 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert…

IJGConline's tweet image. We’re so excited to welcome Zaniru Marín @ZaniruRaul, a #GynOnc trained at the Instituto Nacional de Cancerología #INCan in México 🇲🇽 Let’s give him a warm welcome! 🙌🌟 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert…
0
3
17
0
1K
WorldGOday's profile picture. World Gynecologic Oncology Day – 🌎🌍🌏💜 – is held on Sept 20 every year.
World Gynecologic Oncology Day
 @WorldGOday
Aug 31

September is Gynecologic Cancer Awareness Month! 💜 We are grateful to the #WorldGODay community, the @ESGO_society #gynonc family, and especially our founder, the @ENGAGeESGO network of gyn cancer patient advocacy groups, for all the awareness work they do!

WorldGOday's tweet image. September is Gynecologic Cancer Awareness Month! 💜 We are grateful to the #WorldGODay community, the @ESGO_society #gynonc family, and especially our founder, the @ENGAGeESGO network of gyn cancer patient advocacy groups, for all the awareness work they do!
1
10
21
1
1K
IJGConline's profile picture. IJGC is the primary publication for detection, prevention, diagnosis, & treatment of #GynCancer #GynOnc
IJGC
@IJGConline
May 25, 2024

Rosa Montero @r_monteromac is a Spanish 🇪🇸 #GynOnc working in Poissy Hospital, France, and is part of our team as #EditorialFellow Welcome Rosa!🤩 👋 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4

IJGConline's tweet image. Rosa Montero @r_monteromac is a Spanish 🇪🇸 #GynOnc working in Poissy Hospital, France, and is part of our team as #EditorialFellow Welcome Rosa!🤩 👋 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
0
4
21
0
3K
ozdogan_md's profile picture. Oncologist. Cancer treatment & care in Turkey. Current advances, future directions and second opinion... Let's create a society which is not afraid of cancer!
Mustafa Özdoğan, MD
@ozdogan_md
Oct 19

For the first time, a significant overall survival benefit with immunotherapy in platinum-resistant ovarian cancer! #ESMO25 #Immunotherapy #GynOnc #KeynoteB96 #Oncology @myESMO @OncLive @CParkMD @tugbawitter @Dr_ElvinaA @atakansare2016 @drmukremin @dr_yakupergun @OncoAlert…

ozdogan_md's tweet image. For the first time, a significant overall survival benefit with immunotherapy in platinum-resistant ovarian cancer! #ESMO25 #Immunotherapy #GynOnc #KeynoteB96 #Oncology @myESMO @OncLive @CParkMD @tugbawitter @Dr_ElvinaA @atakansare2016 @drmukremin @dr_yakupergun @OncoAlert…
0
29
57
23
5K
dukeobgyn's profile picture. The Department of Ob/Gyn at Duke University School of Medicine is dedicated to advancing the care of women through research, education, and patient care.
Duke Ob/Gyn
 @dukeobgyn
Mar 27

Research by #gynonc fellow Angela Nolin, MD, published in @SGO_org Daily Coverage at Annual Meeting on Women's Cancer. Study, "Timely endometrial sampling after transvaginal ultrasound: the multi-institutional Performance in Ultrasound Menopausal Bleeding Assessment (PUMBA)."👏

dukeobgyn's tweet image. Research by #gynonc fellow Angela Nolin, MD, published in @SGO_org Daily Coverage at Annual Meeting on Women's Cancer. Study, "Timely endometrial sampling after transvaginal ultrasound: the multi-institutional Performance in Ultrasound Menopausal Bleeding Assessment (PUMBA)."👏
0
1
12
1
1K
Path4People's profile picture. Pathologist 🔬. Co-creator of YouTube’s Pathagonia with @biehlcole. Views = My Own, not my Organization’s. Check us out😃! https://t.co/qC4da8aMpY
Jay "Thymocyte" Hwang
 @Path4People
Jan 13, 2024

Uterine Carcinosarcoma is an interesting tumor to me as a pathologist. It’s a tumor composed of frankly malignant epithelial AND stromal cells. It’s thought that the epithelial component transdifferentiates into a soft tissue component #pathagonia #gynonc #pathx #pathology

Path4People's tweet image. Uterine Carcinosarcoma is an interesting tumor to me as a pathologist. It’s a tumor composed of frankly malignant epithelial AND stromal cells. It’s thought that the epithelial component transdifferentiates into a soft tissue component #pathagonia #gynonc #pathx #pathology
Path4People's tweet image. Uterine Carcinosarcoma is an interesting tumor to me as a pathologist. It’s a tumor composed of frankly malignant epithelial AND stromal cells. It’s thought that the epithelial component transdifferentiates into a soft tissue component #pathagonia #gynonc #pathx #pathology
Path4People's tweet image. Uterine Carcinosarcoma is an interesting tumor to me as a pathologist. It’s a tumor composed of frankly malignant epithelial AND stromal cells. It’s thought that the epithelial component transdifferentiates into a soft tissue component #pathagonia #gynonc #pathx #pathology
3
21
58
16
3K
WashUMedRadOnc's profile picture. Recognized leaders in exceptional patient care, education and research. Affiliated with @SitemanCenter, @WashUmedicine, @BarnesJewish, @STLChildrens.
WashU Medicine Radiation Oncology
 @WashUMedRadOnc
May 3, 2023

Thanks to Dr. Surbhi Grover for a fantastic Wasserman Lecture about #gynonc in Botswana & showing how collaborative research can help around the globe. #Womenwhocurie

WashUMedRadOnc's tweet image. Thanks to Dr. Surbhi Grover for a fantastic Wasserman Lecture about #gynonc in Botswana & showing how collaborative research can help around the globe. #Womenwhocurie
WashUMedRadOnc's tweet image. Thanks to Dr. Surbhi Grover for a fantastic Wasserman Lecture about #gynonc in Botswana & showing how collaborative research can help around the globe. #Womenwhocurie
0
1
29
0
2K
Path4People's profile picture. Pathologist 🔬. Co-creator of YouTube’s Pathagonia with @biehlcole. Views = My Own, not my Organization’s. Check us out😃! https://t.co/qC4da8aMpY
Jay "Thymocyte" Hwang
 @Path4People
Apr 4

63 y/o post menopausal woman with abnormal uterine bleeding 🩸 Imaging found a polyp. Biopsy and subsequent hysterectomy done. Sample of polyp 👇 IHC: p53 mutant, p16 diffuse. Dx? 🤔 #gynpath #gynonc #pathx

Path4People's tweet image. 63 y/o post menopausal woman with abnormal uterine bleeding 🩸 Imaging found a polyp. Biopsy and subsequent hysterectomy done. Sample of polyp 👇 IHC: p53 mutant, p16 diffuse. Dx? 🤔 #gynpath #gynonc #pathx
Path4People's tweet image. 63 y/o post menopausal woman with abnormal uterine bleeding 🩸 Imaging found a polyp. Biopsy and subsequent hysterectomy done. Sample of polyp 👇 IHC: p53 mutant, p16 diffuse. Dx? 🤔 #gynpath #gynonc #pathx
Path4People's tweet image. 63 y/o post menopausal woman with abnormal uterine bleeding 🩸 Imaging found a polyp. Biopsy and subsequent hysterectomy done. Sample of polyp 👇 IHC: p53 mutant, p16 diffuse. Dx? 🤔 #gynpath #gynonc #pathx
Path4People's tweet image. 63 y/o post menopausal woman with abnormal uterine bleeding 🩸 Imaging found a polyp. Biopsy and subsequent hysterectomy done. Sample of polyp 👇 IHC: p53 mutant, p16 diffuse. Dx? 🤔 #gynpath #gynonc #pathx
2
9
22
8
2K
OncBrothers's profile picture. Practice changing discussions by community oncologists-Rohit Gosain @RoswellPark & Rahul Gosain @WilmotCancer. OwnViews/NoMedAdvice.COI https://t.co/cJOjp0RvQE
Oncology Brothers
@OncBrothers
Dec 24

2024 approvals: Summary of 8 new drugs/indications in #BreastCancer & #GynOnc by @US_FDA 1. #Ribociclib 2. #Inavolisib 3. #Pembrolizumab x2 4. #Mirvetuximab 5. #Tisotumab 6. #Dostarlimab 7. #Durvalumab #bcsm #gyncsm #OncTwitter #MedTwitter #HappyHolidays

OncBrothers's tweet image. 2024 approvals: Summary of 8 new drugs/indications in #BreastCancer & #GynOnc by @US_FDA 1. #Ribociclib 2. #Inavolisib 3. #Pembrolizumab x2 4. #Mirvetuximab 5. #Tisotumab 6. #Dostarlimab 7. #Durvalumab #bcsm #gyncsm #OncTwitter #MedTwitter #HappyHolidays
OncBrothers's profile picture. Practice changing discussions by community oncologists-Rohit Gosain @RoswellPark & Rahul Gosain @WilmotCancer. OwnViews/NoMedAdvice.COI https://t.co/cJOjp0RvQE
Oncology Brothers
@OncBrothers
Dec 27, 2023

In 2023, 3 more drugs/indications were approved for #BreastCancer by @FDAOncology @US_FDA: - #Elacestrant in ESR1 HR+ - #Sacituzumab in endocrine resistant HR+ - #Capivasertib in AKT1/PIK3CA/PTEN mutation HR+ #bcsm #OncTwitter #MedTwitter #oncology @ThanksCancer

OncBrothers's tweet image. In 2023, 3 more drugs/indications were approved for #BreastCancer by @FDAOncology @US_FDA: - #Elacestrant in ESR1 HR+ - #Sacituzumab in endocrine resistant HR+ - #Capivasertib in AKT1/PIK3CA/PTEN mutation HR+ #bcsm #OncTwitter #MedTwitter #oncology @ThanksCancer
1
46
101
27
68K
3
84
212
90
57K
IJGConline's profile picture. IJGC is the primary publication for detection, prevention, diagnosis, & treatment of #GynCancer #GynOnc
IJGC
@IJGConline
May 3, 2024

A new cohort of #EditorialFellows is here! Dr. Osnat Elyashiv @osnatelyashiv, a #GynOnc from Israel 🇮🇱 Welcome Osnat, happy to work with you!👋🤩 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4

IJGConline's tweet image. A new cohort of #EditorialFellows is here! Dr. Osnat Elyashiv @osnatelyashiv, a #GynOnc from Israel 🇮🇱 Welcome Osnat, happy to work with you!👋🤩 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
0
5
25
0
2K
dukeobgyn's profile picture. The Department of Ob/Gyn at Duke University School of Medicine is dedicated to advancing the care of women through research, education, and patient care.
Duke Ob/Gyn
 @dukeobgyn
Sep 17, 2024

Positive ovarian cancer clinical trial results highlighted at #ESMO24 in Barcelona, Spain by PICCOLO trial PI #gynonc @AngelesSecord. Promising results: 1/2 of patients in Phase II trial saw cancer shrink or disappear, w/overall response rate of 51.9%. 🔗duke.is/ESMO2024

dukeobgyn's tweet image. Positive ovarian cancer clinical trial results highlighted at #ESMO24 in Barcelona, Spain by PICCOLO trial PI #gynonc @AngelesSecord. Promising results: 1/2 of patients in Phase II trial saw cancer shrink or disappear, w/overall response rate of 51.9%. 🔗duke.is/ESMO2024
0
5
33
0
2K
mboyer_do's profile picture. Gynecologic Oncology Fellow at @UR_Med Greyhound mom, coffee enthusiast, avid knitter.
Megan Boyer, DO, MS
 @mboyer_do
Sep 28, 2024

It’s a Match! We’re headed to University of Rochester for Gynecologic Oncology fellowship! Thank you everyone who helped make this dream a reality. #gynonc #obgynmatch @SGO_org @acog @acogd3 @AOAforDOs

mboyer_do's tweet image. It’s a Match! We’re headed to University of Rochester for Gynecologic Oncology fellowship! Thank you everyone who helped make this dream a reality. #gynonc #obgynmatch @SGO_org @acog @acogd3 @AOAforDOs
mboyer_do's tweet image. It’s a Match! We’re headed to University of Rochester for Gynecologic Oncology fellowship! Thank you everyone who helped make this dream a reality. #gynonc #obgynmatch @SGO_org @acog @acogd3 @AOAforDOs
18
4
431
7
27K
BonaldoGiulio's profile picture. 🇮🇹 🇪🇸 ESGO Fellow - Vall d’Hebron Barcelona Hospital Campus @ijgconline Editorial Fellow
Giulio Bonaldo
 @BonaldoGiulio
Jul 5, 2024

I am really happy to continue my training in gynecologic oncology as an ESGO fellow at Vall d'Hebron Barcelona Hospital Campus! #ESGOfellowship #gynonc 🇪🇸

BonaldoGiulio's tweet image. I am really happy to continue my training in gynecologic oncology as an ESGO fellow at Vall d'Hebron Barcelona Hospital Campus! #ESGOfellowship #gynonc 🇪🇸
6
2
58
0
2K
RiosDoriaMD's profile picture. Gynecologic Oncology Fellow @UWMedicine • Prior Research Fellow @TeamEndo_MSK • ‘23-‘24 @SGO_org Fellow-In-Training Representative • #gyncsm • Posts are my own
Eric Rios-Doria, MD
@RiosDoriaMD
Jan 17, 2024

Are you an #obgyn resident, #gynonc fellow, or recent graduate? Are you attending the @SGO_org Annual Meeting on Women's Cancer? Save the date: Friday, March 15th, 1-4pm for the Resident, Fellow, and Candidate Special Session I'll be co-moderating with Dr. Jess St. Laurent…

RiosDoriaMD's tweet image. Are you an #obgyn resident, #gynonc fellow, or recent graduate? Are you attending the @SGO_org Annual Meeting on Women's Cancer? Save the date: Friday, March 15th, 1-4pm for the Resident, Fellow, and Candidate Special Session I'll be co-moderating with Dr. Jess St. Laurent…
0
4
16
0
2K

Something went wrong.


Something went wrong.


United States Trends